☰

Shannon M. Mumenthaler, Ph.D. - Publications

Affiliations: 
2008 University of California, Los Angeles, Los Angeles, CA 
Area:
Cell Biology, Oncology, Pathology
Tree Info Similar researchers PubMed Report error

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Strelez C, Perez R, Chlystek JS, Cherry C, Yoon AY, Haliday B, Shah C, Ghaffarian K, Sun RX, Jiang H, Lau R, Schatz A, Lenz HJ, Katz JE, Mumenthaler SM. Integration of Patient-Derived Organoids and Organ-on-Chip Systems: Investigating Colorectal Cancer Invasion within the Mechanical and GABAergic Tumor Microenvironment. Biorxiv : the Preprint Server For Biology. PMID 37745376 DOI: 10.1101/2023.09.14.557797  0.313
2023 Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J. Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data. Cell Reports Methods. 3: 100417. PMID 37056380 DOI: 10.1016/j.crmeth.2023.100417  0.337
2021 Strelez C, Ghaffarian K, Mumenthaler SM. Multiplexed imaging and effluent analysis to monitor cancer cell intravasation using a colorectal cancer-on-chip. Star Protocols. 2: 100984. PMID 34927093 DOI: 10.1016/j.xpro.2021.100984  0.308
2020 Garvey CM, Lau R, Sanchez A, Sun RX, Fong EJ, Doche ME, Chen O, Jusuf A, Lenz HJ, Larson B, Mumenthaler SM. Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance. Cancers. 12. PMID 32481658 DOI: 10.3390/Cancers12061393  0.469
2020 Kim S, Choung S, Sun RX, Ung N, Hashemi N, Fong EJ, Lau R, Spiller E, Gasho J, Foo J, Mumenthaler SM. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response. Slas Discovery : Advancing Life Sciences R & D. 2472555220915827. PMID 32349587 DOI: 10.1177/2472555220915827  0.346
2020 Arai H, Xiao Y, Loupakis F, Stintzing S, Wang J, Battaglin F, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Heinemann V, et al. Genetic variants in immunogenic cell death (ICD) relating genes to predict outcome in metastatic colorectal cancer (mCRC): Data from FIRE-3, TRIBE and MAVERICC trials. Journal of Clinical Oncology. 38: 187-187. DOI: 10.1200/Jco.2020.38.4_Suppl.187  0.303
2020 Fong EJ, Kim S, Mumenthaler SM. Abstract B15: Metabolic imaging of patient-derived tumor organoids provides a fast and dynamic readout of drug response Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-B15  0.476
2019 Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, Sands N, O'Connell D, Restrepo-Vassalli S, Chai B, Nemecio D, Punj V, Akbari O, Idos GE, Mumenthaler SM, et al. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nature Communications. 10: 5681. PMID 31831743 DOI: 10.1038/S41467-019-13475-W  0.345
2019 Tokunaga R, Cao S, Naseem M, Battaglin F, Lo JH, Arai H, Loupakis F, Stintzing S, Puccini A, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, et al. AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: a meta-analysis using TRIBE, MAVERICC, and FIRE3. International Journal of Cancer. PMID 30856283 DOI: 10.1002/Ijc.32261  0.321
2019 Puccini A, Loupakis F, Stintzing S, Cao S, Battaglin F, Togunaka R, Naseem M, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, et al. Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3. European Journal of Cancer (Oxford, England : 1990). 111: 138-147. PMID 30852420 DOI: 10.1016/J.Ejca.2019.01.105  0.31
2019 Tokunaga R, Cao S, Battaglin F, Lo JH, Loupakis F, Stintzing S, Naseem M, Puccini A, Berger MD, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, et al. Th17 cell pathway-related genetic variants in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC, and FIRE-3. Journal of Clinical Oncology. 37: 594-594. DOI: 10.1200/Jco.2019.37.4_Suppl.594  0.353
2018 Liu X, Lukowski JK, Flinders C, Georgiadis R, Kim S, Mumenthaler S, Hummon AB. MALDI-MSI of Immunotherapy: Mapping the EGFR-Targeting Antibody Cetuximab in 3D Colon Cancer Cell Cultures. Analytical Chemistry. PMID 30479121 DOI: 10.1021/Acs.Analchem.8B02151  0.706
2018 Chiang CT, Demetriou AN, Ung N, Choudhury N, Ghaffarian K, Ruderman DL, Mumenthaler SM. mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer. Cancer Letters. PMID 30036610 DOI: 10.1016/J.Canlet.2018.07.025  0.38
2018 Patsch K, Mumenthaler SM, Ruderman D. Image-Based Tracking of Heterogeneous Single-Cell Phenotypes. Methods in Molecular Biology (Clifton, N.J.). 1745: 47-63. PMID 29476462 DOI: 10.1007/978-1-4939-7680-5_3  0.363
2018 Ghaffarizadeh A, Heiland R, Friedman SH, Mumenthaler SM, Macklin P. PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems. Plos Computational Biology. 14: e1005991. PMID 29474446 DOI: 10.1371/Journal.Pcbi.1005991  0.361
2018 Chiang C, Ung N, Demetriou AN, Chiu C, Choudhury N, Arnesano C, Fraser SE, Agus DB, Matasci N, Ruderman DL, Mumenthaler SM. Abstract 2414: Interrogating cellular metabolism reveals mTORC2 as a new biomarker to stratify epidermal growth factor receptor-mutant non-small cell lung cancer Cancer Research. 78: 2414-2414. DOI: 10.1158/1538-7445.Am2018-2414  0.424
2017 Liu X, Flinders C, Mumenthaler SM, Hummon AB. MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids. Journal of the American Society For Mass Spectrometry. PMID 29209911 DOI: 10.1007/S13361-017-1851-4  0.697
2017 Garvey CM, Gerhart TA, Mumenthaler SM. Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques. Journal of Visualized Experiments : Jove. PMID 28715383 DOI: 10.3791/55844  0.406
2017 Garvey CM, Chen O, Lau R, Mumenthaler SM. Abstract B13: High-content imaging to quantitate colorectal cancer associated fibroblast heterogeneity Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B13  0.488
2017 Patsch K, Soundararajan A, Engeln M, Gross ME, Mumenthaler SM, Ruderman D. Abstract A29: Heterogeneity of androgen receptor dynamics and drug response in prostate cancer cells Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-A29  0.426
2017 Garvey CM, Chen O, Mumenthaler SM. Abstract 5908: Cancer-associated fibroblast driven drug resistance in colorectal cancer Cancer Research. 77: 5908-5908. DOI: 10.1158/1538-7445.Am2017-5908  0.404
2017 Spiller E, Lau R, Flinders C, Mumenthaler S. Abstract 4835: A robust, non-destructive image analysis method for the quantitation and characterization of patient derived organoids Cancer Research. 77: 4835-4835. DOI: 10.1158/1538-7445.Am2017-4835  0.646
2017 Flinders C, Alwash N, Mumenthaler S. Abstract 4521: Long term hypoxia induces stable overexpression of JUNB and the TGFβ pathway in colon cancer Cancer Research. 77: 4521-4521. DOI: 10.1158/1538-7445.Am2017-4521  0.666
2016 Macklin P, Frieboes HB, Sparks JL, Ghaffarizadeh A, Friedman SH, Juarez EF, Jonckheere E, Mumenthaler SM. Progress Towards Computational 3-D Multicellular Systems Biology. Advances in Experimental Medicine and Biology. 936: 225-246. PMID 27739051 DOI: 10.1007/978-3-319-42023-3_12  0.399
2016 Patsch K, Chiu CL, Engeln M, Agus DB, Mallick P, Mumenthaler SM, Ruderman D. Single cell dynamic phenotyping. Scientific Reports. 6: 34785. PMID 27708391 DOI: 10.1038/Srep34785  0.56
2016 Juarez EF, Lau R, Friedman SH, Ghaffarizadeh A, Jonckheere E, Agus DB, Mumenthaler SM, Macklin P. Quantifying differences in cell line population dynamics using CellPD. Bmc Systems Biology. 10: 92. PMID 27655224 DOI: 10.1186/S12918-016-0337-5  0.328
2016 Lindsay D, Garvey CM, Mumenthaler SM, Foo J. Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors. Plos Computational Biology. 12: e1005077. PMID 27560187 DOI: 10.1371/Journal.Pcbi.1005077  0.404
2016 Park SM, Lee JY, Hong S, Lee SH, Dimov IK, Lee H, Suh S, Pan Q, Li K, Wu AM, Mumenthaler SM, Mallick P, Lee LP. Dual transcript and protein quantification in a massive single cell array. Lab On a Chip. PMID 27546183 DOI: 10.1039/C6Lc00762G  0.591
2016 Garvey CM, Spiller E, Lindsay D, Chiang CT, Choi NC, Agus DB, Mallick P, Foo J, Mumenthaler SM. A high-content image-based method for quantitatively studying context-dependent cell population dynamics. Scientific Reports. 6: 29752. PMID 27452732 DOI: 10.1038/Srep29752  0.584
2016 Yadav VK, Smith KS, Flinders C, Mumenthaler SM, De S. Significance of duon mutations in cancer genomes. Scientific Reports. 6: 27437. PMID 27272679 DOI: 10.1038/Srep27437  0.668
2016 Spiller E, Lau R, Choung S, Mumenthaler SM. Abstract A18: High-content 3D image analysis of patient-derived organoids Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-A18  0.41
2016 Garvey CM, Chen O, Foo J, Mumenthaler SM. Abstract C39: High-content screening to capture tumor dynamics in response to microenvironmental perturbations Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-C39  0.472
2016 Flinders C, Liu S, Mumenthaler S. Abstract C08: Stability of hypoxia induced expression of colon cancer metastasis-associated genes Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-C08  0.686
2016 Chiang C, Chiu C, Arnesano C, Fraser SE, Agus DB, Ruderman DL, Mumenthaler SM. Abstract B36: Interrogating cellular metabolism to improve therapy for EGFR mutant NSCLC Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B36  0.422
2016 Liu S, Bainer R, Yui Y, Flinders C, Mallick P, Weaver V, Mumenthaler S. Abstract A23: Characterization of diverging molecular and phenotypic responses under changing extracellular matrix stiffness in MCF10A cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A23  0.738
2015 Yang-Kolodji G, Mumenthaler SM, Mehta A, Ji L, Tripathy D. Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 20: 313-22. PMID 26329528 DOI: 10.3109/1354750X.2015.1068865  0.305
2015 Mumenthaler SM, Foo J, Choi NC, Heise N, Leder K, Agus DB, Pao W, Michor F, Mallick P. The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells. Cancer Informatics. 14: 19-31. PMID 26244007 DOI: 10.4137/Cin.S19338  0.622
2015 Frieboes HB, Smith BR, Wang Z, Kotsuma M, Ito K, Day A, Cahill B, Flinders C, Mumenthaler SM, Mallick P, Simbawa E, Al-Fhaid AS, Mahmoud SR, Gambhir SS, Cristini V. Predictive Modeling of Drug Response in Non-Hodgkin's Lymphoma. Plos One. 10: e0129433. PMID 26061425 DOI: 10.1371/Journal.Pone.0129433  0.72
2015 Bainer R, Yui Y, Mumenthaler S, Mallick P, Liu L, Wu H, Podlaha O, Michor F, Liphardt J, Licht J, Weaver V. Abstract PR09: Extracellular stiffness cues drive spatial reorganization of the genome to globally constrain RNA abundance Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr09  0.56
2015 Mumenthaler S, Foo J, Choi N, Pao W, Agus D, Michor F, Mallick P. Abstract PR16: Spatio-temporal heterogeneity in the tumor microenvironment influences the evolutionary dynamics of drug resistance Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr16  0.609
2014 Li K, Tavaré R, Zettlitz KA, Mumenthaler SM, Mallick P, Zhou Y, Marks JD, Wu AM. Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments. Molecular Cancer Therapeutics. 13: 2607-17. PMID 25143449 DOI: 10.1158/1535-7163.Mct-14-0363  0.596
2014 Bainer R, Yui Y, Mumenthaler S, Mallick P, Podlaha O, Michor F, Liphardt J, Licht J, Weaver V. Abstract 2344: 3D extracellular stiffness cues drive localized changes in gene expression Cancer Research. 74: 2344-2344. DOI: 10.1158/1538-7445.Am2014-2344  0.591
2013 Mumenthaler SM, D'Antonio G, Preziosi L, Macklin P. The Need for Integrative Computational Oncology: An Illustrated Example through MMP-Mediated Tissue Degradation. Frontiers in Oncology. 3: 194. PMID 23898463 DOI: 10.3389/Fonc.2013.00194  0.302
2013 Agus DB, Alexander JF, Arap W, Ashili S, Aslan JE, Austin RH, Backman V, Bethel KJ, Bonneau R, Chen WC, Chen-Tanyolac C, Choi NC, Curley SA, Dallas M, ... ... Mumenthaler SM, et al. A physical sciences network characterization of non-tumorigenic and metastatic cells. Scientific Reports. 3: 1449. PMID 23618955 DOI: 10.1038/Srep01449  0.577
2013 Foo J, Leder K, Mumenthaler SM. Cancer as a moving target: understanding the composition and rebound growth kinetics of recurrent tumors. Evolutionary Applications. 6: 54-69. PMID 23396647 DOI: 10.1111/Eva.12019  0.367
2013 Park S, Lee JY, Hong S, Dimov IK, Li K, Wu AM, Mumenthaler S, Mallick P, Lee LP. Concurrent Transcript and Protein Quantification in a Massive Single Cell Array Enables Population-Wide Observation of Oncogene Escape Biophysical Journal. 104: 686a. DOI: 10.1016/J.Bpj.2012.11.3790  0.617
2012 Gonzalez-Malerva LG, Park J, Velmurugan K, LaBaer J, Mumenthaler S. Abstract 5124: Genomic and proteomic characterization of tamoxifen sensitive and resistant MCF7 cells Cancer Research. 72: 5124-5124. DOI: 10.1158/1538-7445.Am2012-5124  0.401
2011 Mumenthaler SM, Foo J, Leder K, Choi NC, Agus DB, Pao W, Mallick P, Michor F. Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Molecular Pharmaceutics. 8: 2069-79. PMID 21995722 DOI: 10.1021/Mp200270V  0.591
2009 Mumenthaler SM, Ng PY, Hodge A, Bearss D, Berk G, Kanekal S, Redkar S, Taverna P, Agus DB, Jain A. Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Molecular Cancer Therapeutics. 8: 2882-93. PMID 19825806 DOI: 10.1158/1535-7163.Mct-09-0293  0.389
2008 Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW. Disruption of arginase II alters prostate tumor formation in TRAMP mice. The Prostate. 68: 1561-9. PMID 18663728 DOI: 10.1002/Pros.20816  0.548
2008 Mumenthaler SM, Yu H, Tze S, Cederbaum SD, Pegg AE, Seligson DB, Grody WW. Expression of arginase II in prostate cancer. International Journal of Oncology. 32: 357-65. PMID 18202758 DOI: 10.3892/Ijo.32.2.357  0.569
2006 Orkin MB, Mumenthaler SM, Cederbaum S, Grody W. 438 ARGINASE AS A PROLIFERATIVE DETERMINANT IN PROSTATE CANCER. Journal of Investigative Medicine. 54: S155.2-S155. DOI: 10.2310/6650.2005.X0004.437  0.546
Show low-probability matches.